retatrutide obesity phase 2 trial study sees significant weight loss in drug study Retatrutide—A Game Changer in Obesity

Clinical trials specifically include patients who plateaued on other treatments

Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide, dulaglutide, and liraglutide are subcutaneous injections used for type 2 diabetes and weight management

Treatment typically involves rhythm or rate control medication, anticoagulation, and, in many cases, catheter ablation to restore normal rhythm

Eligibility for the new program hinges on your BMI and whether you have a related condition like prediabetes, heart disease, or high blood pressure

th Isnt that the responsibility of the private provider who has put them on treatment?

Those with type 3 also experience neurological complications